These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27524416)

  • 1. mTOR promotes pituitary tumor development through activation of PTTG1.
    Chen R; Duan J; Li L; Ma Q; Sun Q; Ma J; Li C; Zhou X; Chen H; Jing Y; Zhao S; Wu X; Zhang H
    Oncogene; 2017 Feb; 36(7):979-988. PubMed ID: 27524416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
    Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
    Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells.
    Vlotides G; Cruz-Soto M; Rubinek T; Eigler T; Auernhammer CJ; Melmed S
    Mol Endocrinol; 2006 Dec; 20(12):3321-35. PubMed ID: 16959877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of PTTG1 inhibits cell angiogenesis, migration and invasion in glioma cells.
    Cui L; Ren T; Zhao H; Chen S; Zheng M; Gao X; Feng D; Yang L; Jin X; Zhuo R
    Med Oncol; 2020 Jul; 37(8):73. PubMed ID: 32725378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis.
    Hatcher RJ; Dong J; Liu S; Bian G; Contreras A; Wang T; Hilsenbeck SG; Li Y; Zhang P
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1008-13. PubMed ID: 24395789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression.
    Horwitz GA; Miklovsky I; Heaney AP; Ren SG; Melmed S
    Mol Endocrinol; 2003 Apr; 17(4):600-9. PubMed ID: 12554778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
    Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
    Zha X; Hu Z; Ji S; Jin F; Jiang K; Li C; Zhao P; Tu Z; Chen X; Di L; Zhou H; Zhang H
    Cancer Lett; 2015 Apr; 359(1):97-106. PubMed ID: 25578782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological targeting of mammalian target of rapamycin inhibits ovarian granulosa cell tumor growth.
    Rico C; Laguë MN; Lefèvre P; Tsoi M; Dodelet-Devillers A; Kumar V; Lapointe E; Paquet M; Nadeau MÈ; Boerboom D
    Carcinogenesis; 2012 Nov; 33(11):2283-92. PubMed ID: 22871496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality.
    Ma A; Wang L; Gao Y; Chang Z; Peng H; Zeng N; Gui YS; Tian X; Li X; Cai B; Zhang H; Xu KF
    Hum Mol Genet; 2014 Feb; 23(3):693-705. PubMed ID: 24129405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.
    Huang SQ; Liao QJ; Wang XW; Xin DQ; Chen SX; Wu QJ; Ye G
    Braz J Med Biol Res; 2012 Nov; 45(11):995-1001. PubMed ID: 22872288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma.
    Diegel CR; Cho KR; El-Naggar AK; Williams BO; Lindvall C
    Cancer Res; 2010 Nov; 70(22):9143-52. PubMed ID: 21062985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma.
    Kong B; Cheng T; Qian C; Wu W; Steiger K; Cao J; Schlitter AM; Regel I; Raulefs S; Friess H; Erkan M; Esposito I; Kleeff J; Michalski CW
    Mol Cancer; 2015 Dec; 14():212. PubMed ID: 26683340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice.
    Dai C; Zhang B; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wang J; Guo K; Ma W; Xing B; Lian W; Xiao J; Cai F; Zhang H; Wang R
    Endocrinology; 2013 Mar; 154(3):1247-59. PubMed ID: 23384836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overactive mTOR signaling leads to endometrial hyperplasia in aged women and mice.
    Bajwa P; Nielsen S; Lombard JM; Rassam L; Nahar P; Rueda BR; Wilkinson JE; Miller RA; Tanwar PS
    Oncotarget; 2017 Jan; 8(5):7265-7275. PubMed ID: 27980219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.
    Neshat MS; Mellinghoff IK; Tran C; Stiles B; Thomas G; Petersen R; Frost P; Gibbons JJ; Wu H; Sawyers CL
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10314-9. PubMed ID: 11504908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the mTOR pathway regulators in human pituitary adenomas indicates the clinical course.
    Jia W; Sanders AJ; Jia G; Liu X; Lu R; Jiang WG
    Anticancer Res; 2013 Aug; 33(8):3123-31. PubMed ID: 23898069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.
    Yang H; Wang X; Zhang Y; Liu H; Liao J; Shao K; Chu Y; Liu G
    J Cell Physiol; 2014 Jan; 229(1):17-26. PubMed ID: 23804073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
    Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
    Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.